Company
Moderna, Inc.
Headquarters: Cambridge, MA, United States
Founded: September 2010
Employees: 2,700
CEO: Mr. Stephane Bancel
Market Cap
$68.42 Billion
USD as of Jan. 1, 2023
Moderna, Inc. Categories
United States
languages
Healthcare
languages
Biotechnology
United States Healthcare
United States Biotechnology
Company Description
Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
Novo Nordisk
|
$304.61 B |
CSL Limited
|
$93.24 B |
|
Regeneron Pharmaceuticals, Inc.
|
$79.53 B |
| Marinomed Biotech AG | $76.72 B |
|
Vertex Pharmaceuticals Incorporated
|
$74.13 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$495.37 B |
|
Johnson & Johnson
|
$461.85 B |
|
Lilly
|
$347.61 B |
|
Novo Nordisk
|
$304.61 B |
|
Pfizer
|
$287.63 B |
Detailed Description
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Stocks & Indices
Moderna, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MRNA
Stock: BMV: MRNA
Stock: Bovespa: M1RN34
Stock: FSX: 0QF
Product & Services
Moderna COVID-19 vaccine
Key People
Founder(s): Derrick Rossi Timothy A. Springer Robert S. Langer Kenneth R. Chien Noubar Afeyan
Stéphane Bancel, CEO Stephen Hoge, President David Meline, CFO Noubar Afeyan, Chairman Robert S. Langer, Director Paul Sagan, Director
Financials
Revenue: US$18.5 billion (2021)
Operating income: US$13.3 billion (2021)
Net income: US$12.2 billion (2021)
Total assets: US$24.7 billion (2021)
Total equity: US$24.7 billion (2021)